Mabwell (SSE: 688062) is an innovation-driven biopharmaceutical company with an entire industry chain of R&D, manufacturing, and commercialization. Consistent with our commitment to provide more effective and accessible therapies and innovative products, Mabwell has worked to fulfill global medical needs and bring life-changing solutions to patients.
